What You Should Know: - Seed Healthv, a microbial sciences company, announced the acquisition of Auggi, a digital health company with a suite of artificial intelligence and machine learning technologies to track and analyze digestive health. - As part of the acquisition, Seed Health will acquire Auggi's technology assets, including its AI algorithm for real-time Bristol stool typing, the world's largest stool image database, and a mobile monitoring application for clinical research. -
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Why Cancer Registries are Part of America’s Fight for Racial Equality
According to a 2019 study in the Proceedings of the National Academy of Sciences, one in 1,000 Black males can expect to die at the hands of the police. Black males were also 2.5 times more likely to die during an encounter with police than white males. For some, those figures are staggering. For many others, they are reminders of the racial disparities that have existed for far too long in this country. So, in 2020, when recent events have brought racial injustice back into the national
Read More
Flywheel Nabs $15M for Next-Gen Informatics Platform for Medical Research & Collaboration
What You Should Know: - Minneapolis-based digital health startup Flywheel raies $15M in Series B funding to advance the use of AI in clinical trials co-led by Beringea and 8VC including participation from Novartis dRx Capital, Hewlett Packard Enterprise (HPE), Great North Labs, iSelect and Argonautic Ventures. - By leveraging cloud scalability and automating research workflows, Flywheel helps organizations scale research data and analysis, improve scientific collaboration and
Read More
Cedars Sinai Launches COVID-19 Recovery Program
What You Should Know: - Patients in the Cedars-Sinai COVID-19 Recovery Program receive a comprehensive in-person evaluation with an expert in infectious diseases or pulmonary medicine who can refer them to a network of specialists. Cedars-Sinai, today announce the launch of the COVID-19 Recovery Program to meet the needs of a growing number of COVID-19 patients who experience lingering symptoms weeks and even months after physicians say they are virus-free. COVID-19
Read More
Why A Patient-First Strategy for Specialty Rx Pharmacists Is Critical to Optimize Outcomes
One of the biggest challenges for biopharmaceutical companies of rare and orphan disease patient populations is optimizing disease management in a way that enhances the patient journey and improves outcomes. As these companies seek innovative solution partners, a patient-first approach that offers specialty Rx pharmacist expertise is critical for securing insurance coverage, coordinating care, ensuring compliance, and, ultimately, minimizing the daily impact of rare and orphan
Read More
Xealth’s CEO Shares Impact of Digital Health in 2020 and What’s Ahead in 2021
HIT Consultant sat down with Mike McSherry, CEO, and co-founder of Seattle-based digital prescription platform Xealth to discuss digital health lessons learned in 2020 and what we can expect in 2021. As Xealth’s CEO, Mike also works with Duke Health, UPMC, Atrium Health, and The Froedtert & the Medical College of Wisconsin health network where he uses his background in digital health to connect patients and care teams outside of traditional care settings. HITC: In 2021, How can digital
Read More
30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
As we close out the year, we asked several healthcare executives to share their predictions and trends for 2021. Kimberly Powell, Vice President & General Manager, NVIDIA Healthcare Federated Learning: The clinical community will increase their use of federated learning approaches to build robust AI models across various institutions, geographies, patient demographics, and medical scanners. The sensitivity and selectivity of these models are outperforming AI models
Read More
Patient-First Model: High Tech Meets High Touch for Individuals with Rare Disorders
Industry experts state that orphan drugs will be a major trend to watch in the years ahead, accounting for almost 40% of the Food and Drug Administration approvals this year. This market has become more competitive in the past few years, increasing the potential for reduced costs and broader patient accessibility. Currently, these products are often expensive because they target specific conditions and cost on average $147,000 or more per year, making commercialization
Read More
M&A: Philips Acquires Remote Cardiac Monitoring BioTelemetry for $2.8B
What You Should Know: - Philips acquires BioTelemetry, a U.S. provider of remote cardiac diagnostics and monitoring for $72.00 per share for an implied enterprise value of $2.8 billion (approx. EUR 2.3 billion). - With $439M in revenue in 2019, BioTelemetry annually monitors over 1 million cardiac patients remotely; its portfolio includes wearable heart monitors, AI-based data analytics, and services. - BioTelemetry business is expected to deliver double-digit growth and improve its
Read More
Amazon Launches HealthLake for Healthcare Orgs to Aggregate & Structure Health Data
What You Should Know: - Amazon today announced the launch of Amazon HealthLake, a new HIPAA-eligible service enables healthcare organizations to store, tag, index, standardize, query, and apply machine learning to analyze data at petabyte scale in the cloud. - Cerner, Ciox Health, Konica Minolta Precision Medicine, and Orion Health among customers using Amazon HealthLake. Today at AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com company today announced Amazon
Read More